Today's pre-market stock movers: CHWY, PATH, SNAP, HPE and more

• $Repare Therapeutics(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)

• $Chewy(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)

• $UiPath(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)

• $Pure Storage(PSTG.US)$ +10.6% (In reaction to earnings)

• $Credo Technology(CRDO.US)$ +10.2% (In reaction to earnings)

• $Blue Apron(APRN.US)$ +9.4% (launches new meal kit offering on )Walmart.com

• $MongoDB(MDB.US)$ +9.2% (In reaction to earnings)

• $Nextdoor Holdings(KIND.US)$ +7.1% (authorizes new $100 mln share repurchase program)

• $Elastic(ESTC.US)$ +6.5% (In reaction to earnings)

• $Sana Biotechnology(SANA.US)$ +5.6% (to develop manufacturing facility in Bothell)

• $Veeva Systems(VEEV.US)$ +4.3%(In reaction to earnings)

• $PVH Corp(PVH.US)$ +4.1% (also increases planned 2022 share repurchases to $400 mln),

• $Designer Brands(DBI.US)$ +4% (In reaction to earnings)

• $NetApp(NTAP.US)$+3.4% (In reaction to earnings)

• $Secureworks(SCWX.US)$ +3.3% (In reaction to earnings)

• $SpartanNash(SPTN.US)$ +2.9% (In reaction to earnings)

• $Comtech Telecommunications(CMTL.US)$ +2.7% (receives 5G contract with mobile network operator in Saudi Arabia)

• $ANI Pharmaceuticals(ANIP.US)$ +2.5% (receives FDA approval for ANDA for Fludrocortisone Acetate Tablets)

• $Ferroglobe(GSM.US)$ +2.5% (names new COO)

• $ASGN Inc(ASGN.US)$ +2.3% (acquires GlideFast Consulting for $350 mln; reaffirms Q2 outlook)

• $Riot Platforms(RIOT.US)$ +1.5% (names new CFO)

• $DHI Group(DHX.US)$+1.4% (US PTO issues patent related to taxonomy)

• $Silk Road Medical(SILK.US)$ +1.3% (CMS has expanded coverage for TCAR to include standard surgical risk patients within the VQI's TCAR

• $Cedar Fair(FUN.US)$+1.1% (YTD update)

• $Boyd Gaming(BYD.US)$+1.1% (authorizes $500 mln increase to share repurchase program)

• $Semtech(SMTC.US)$+1% (In reaction to earnings)

• $Descartes Systems Group(DSGX.US)$ +0.9% (In reaction to earnings)

• $GameStop(GME.US)$+0.8% (In reaction to earnings)

• $SolarEdge Technologies(SEDG.US)$ +3.5% (upgraded to Outperform from Perform at Oppenheimer)

• $Wolfspeed(WOLF.US)$ +3.5% (upgraded to Outperform from Perform at Oppenheimer)

• $Ecolab(ECL.US)$+1.6% (upgraded to Buy from Neutral at UBS)

• $Americold Realty Trust(COLD.US)$ +1.4% (upgraded to Neutral from Underperform at BofA Securities)

• $Agree Realty Corp(ADC.US)$ +1.3% (upgraded to Buy from Neutral at BofA Securities)

• $Dentsply Sirona(XRAY.US)$+1.1% (upgraded to Buy from Neutral at UBS)

Losers:

• $Immunic(IMUX.US)$ -62.2% (reported top-line data from its phase 2 CALDOSE-1 trial of lead asset, vidofludimus calcium)

• $C3.ai(AI.US)$-19.4%(In reaction to earnings)

• $Ozon Holdings(OZON.US)$ -19% (enters into standstill agreement for $750 mln convertible bonds)

• $Centessa Pharmaceuticals(CNTA.US)$-8.9% (to discontinue clinical development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease)

• $Hewlett Packard Enterprise(HPE.US)$-5.5% (earnings and sales miss amid 'inflationary environment and ongoing supply-chain disruptions')

• $Concert Pharmaceuticals(CNCE.US)$ -5% (prices offering of 10 mln shares of common stock at $4.75 per share)

• $Magnolia Oil & Gas(MGY.US)$ -4.7% (announces proposed block trade of 7.5 mln Class A shares by selling shareholders; intends to purchase 2 mln Class B shares)

• $Blue Owl Capital(OWL.US)$ -3.1% (prices secondary offering by NBSH Blue Investments II of 10,698,180 shares of Class A common stock at $11.50 per share)

• $American Tower Corp(AMT.US)$-2.9% (intends to offer 8,350,000 shares of its common stock in a registered public offering)

• $Ciena(CIEN.US)$-2.8% (In reaction to earnings)

• $International Game Technology(IGT.US)$-1.7% (signs ten year contract extension with Kansas lottery)

• $SentinelOne(S.US)$ -1.7% (In reaction to earnings)

• $Moderna(MRNA.US)$ -1.4% (Moderna and EC to amend their originally agreed contractual delivery schedules for the Moderna COVID-19 vaccine booster product (Spikevax, mRNA-1273) or updated booster vaccine candidate)

• $ArcBest(ARCB.US)$ -1.3% (guidance update)

• $Enochian Biosciences(ENOB.US)$ -1.2% (published on its website a letter to shareholders to clarify "several misrepresentations")

• $Radius Health(RDUS.US)$ -1.1% (provides update on abaloparatide transdermal system; to cease all work on abalo-TDS)

• $Day One Biopharmaceuticals(DAWN.US)$ -0.9% (files for $400 mln mixed securities shelf offering)

• $Pinterest(PINS.US)$ -2.7% (downgraded to Neutral from Overweight at Piper Sandler)

• $Twilio(TWLO.US)$ -2.7% (downgraded to Equal Weight from Overweight at Barclays)

• $Albemarle(ALB.US)$-2.3% (downgraded to Neutral from Buy at UBS)

• $Snap Inc(SNAP.US)$ -1.8% (downgraded to Neutral from Overweight at Piper Sandler)

• $Crown Castle(CCI.US)$-1.6% (downgraded to Underweight from Equal Weight at Wells Fargo)

• $Starry Group(STRY.US)$ -1.6% (downgraded to Neutral from Buy at Goldman)